Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies (Q39569852)

13 September 2017

Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies (English)

1 reference

13 September 2017

chronic myeloid leukemia

0 references

1 reference

7

Gianantonio Rosti

1 reference

13 September 2017

8

Michele Baccarani

1 reference

13 September 2017

2

Massimo Breccia

1 reference

13 September 2017

1

Fabio Efficace

1 reference

13 September 2017

Francesco Cottone

3

1 reference

13 September 2017

Iris Okumura

series ordinal

4

1 reference

13 September 2017

Maribel Doro

series ordinal

5

1 reference

13 September 2017

Francesca Riccardi

series ordinal

6

1 reference

13 September 2017

23 July 2016

1 reference

Supportive Care in Cancer

13 September 2017

1 reference

13 September 2017

24

1 reference

13 September 2017

12

1 reference

13 September 2017

4887-4894

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-016-3344-6

13 September 2017

0 references

cites work

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Educational session: managing chronic myeloid leukemia as a chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

The impact of symptom burden on patient quality of life in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

From social integration to health: Durkheim in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Association of social support, functional status, and psychological variables with changes in health-related quality of life outcomes in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

The role of attachment dimensions and perceived social support in predicting adjustment to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Social networks and quality of life for long-term survivors of leukemia and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Post-traumatic Growth in the Italian Experience of Long-term Disease-free Cancer Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

The need for psychosocial support and its determinants in a sample of patients undergoing radiooncological treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Breast cancer survivors' recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Social networks and quality of life among female long‐term colorectal cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Anxiety and depression in long-term testicular germ cell tumor survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Explaining age-related differences in depression following breast cancer diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

The process of recovery from breast cancer for younger and older patients. Changes during the first year.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Psychological impact of lymphoma on adolescents and young adults: not a matter of black or white

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Milestones and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-016-3344-6

Social Support and Psychological Distress in Primary Care Attenders

21 January 2018

1 reference

12 December 2020

Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

1 reference

12 December 2020

Social networks, social support, and survival after breast cancer diagnosis

1 reference

12 December 2020

Psychometric characteristics of the Multidimensional Scale of Perceived Social Support.

1 reference

12 December 2020

10.1007/S00520-016-3344-6

Identifiers

DOI

1 reference

13 September 2017

1 reference